E-LIB Suche - Ergebnisse für: de la Fuente, Rocio Aller

1

The metabolic dysfunction-associated fatty liver disease de..:

Del Barrio Azaceta, María ; Iruzubieta, Paula ; de la Fuente, Rocio Aller...
Journal of Hepatology. 77 (2022) - p. S158-S159 , 2022

Link: https://doi.org/10.1016/..

2

The practical utility of non-invasive indices in metabolic ..:

Tafur Sánchez, Carla Noemi ; Durá Gil, Miguel ; Alemán Domínguez del Río, Andrea...
Endocrinología, Diabetes y Nutrición (English ed.). 69 (2022) 6 - p. 418-425 , 2022

Link: https://doi.org/10.1016/..

3

Metabolic dysfunction-associated fatty liver disease increa..:

Del Barrio Azaceta, María ; Iruzubieta, Paula ; De La Fuente, Rocio Aller...
Journal of Hepatology. 77 (2022) - p. S157 , 2022

Link: https://doi.org/10.1016/..

4

Leptin Receptor Lys656Asn Polymorphism Is Associated with D..:

de Luis Roman, Daniel ; de la Fuente, Rocio Aller ; Sagrado, Manuel Gonzalez..
Archives of Medical Research. 37 (2006) 7 - p. 854-859 , 2006

Link: https://doi.org/10.1016/..

5

Predicting liver-related events in NAFLD: A predictive mode:

Calzadilla-Bertot, Luis ; Jeffrey, Gary P. ; Wang, Zhengyi...
Hepatology. 78 (2023) 4 - p. 1240-1251 , 2023

Link: https://doi.org/10.1097/..

6

Metabolic subtypes of patients with NAFLD exhibit distincti..:

Martínez‐Arranz, Ibon ; Bruzzone, Chiara ; Noureddin, Mazen...
Hepatology. 76 (2022) 4 - p. 1121-1134 , 2022

Link: https://doi.org/10.1002/..

7

Nutrition and Chronic Liver Disease:

Aller de la Fuente, Rocío
Clinical Drug Investigation. 42 (2022) S1 - p. 55-61 , 2022

Link: https://doi.org/10.1007/..

8

Metabolomic‐based noninvasive serum test to diagnose nonalc..:

Mayo, Rebeca ; Crespo, Javier ; Martínez‐Arranz, Ibon...
Hepatology Communications. 2 (2018) 7 - p. 807-820 , 2018

Link: https://doi.org/10.1002/..

9

Histopathological differences in patients with biopsy-prove..:

Aller de la Fuente, Rocío ; Mora Cuadrado, Natalia ; Tafur, Carla...
Endocrinología, Diabetes y Nutrición (English ed.). 65 (2018) 6 - p. 354-360 , 2018

Link: https://doi.org/10.1016/..

10

Impact of the endoscopist's experience on the negative pred..:

Velayos Jiménez, Benito ; Alcaide Suárez, Noelia ; González Redondo, Guillermo...
Gastroenterología y Hepatología (English Edition). 40 (2017) 1 - p. 10-15 , 2017

Link: https://doi.org/10.1016/..

11

Metabolic subtypes of patients with NAFLD exhibit distincti..:

Martínez‐Arranz, Ibon ; Bruzzone, Chiara ; Noureddin, Mazen...
qt6972c0dv. , 2022

Link: https://escholarship.org..

12

Metabolomic‐based noninvasive serum test to diagnose nonalc..:

Mayo, Rebeca ; Crespo, Javier ; Martínez‐Arranz, Ibon...
qt8421g0p6. , 2018

Link: https://escholarship.org..

13

Fibrosis Severity as a Determinant of Cause-Specific Mortal..:

Vilar-Gomez, Eduardo ; Calzadilla-Bertot, Luis ; Wai-Sun Wong, Vincent...
Gastroenterology. 155 (2018) 2 - p. 443-457.e17 , 2018

Link: https://doi.org/10.1053/..

14

Nutrition and Chronic Liver Disease:

Aller de la Fuente, Rocío
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205793/. , 2022

Link: http://www.ncbi.nlm.nih...

15

Metabolic subtypes of patients with NAFLD exhibit distincti..:

Martínez Arranz, Ibon ; Bruzzone, Chiara ; Noureddin, Mazen...
info:eu-repo/grantAgreement/EC/H2020/777377. , 2022

Link: http://hdl.handle.net/10..